How many email patterns does Bicara Therapeutics use?

Bicara Therapeutics uses 1 known email pattern.

What domain does Bicara Therapeutics use for work emails?

Bicara Therapeutics uses bicara.com for work email addresses.

Most Common Email Formats at Bicara Therapeutics

The most accurate and popular Bicara Therapeutics's email format is First.Last@bicara.com (ex. John.Doe@bicara.com). Bicara Therapeutics also uses as email structures. Bicara Therapeutics uses up to 1 different email patterns.

Bicara Therapeutics Email Formats	Example	Percentage
First.Last@bicara.com	John.Doe@bicara.com	100%

Bicara Therapeutics Email Formats

Example

Percentage

First.Last@bicara.com

John.Doe@bicara.com

100%

Frequently Asked Questions

What does Bicara Therapeutics do?

Bicara Therapeutics was founded in 2020. The company's main headquarters is located in Boston, Massachusetts United Statesoperates in the Biotechnology Research industry, along with similar companies like Harpoon TherapeuticsRocheXencor. You can visit bicara.com. Explore Bicara Therapeutics's company overview page for more information.

What is Bicara Therapeutics's email address format?

Bicara Therapeutics's email format typically follows the pattern of First.Last@bicara.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Bicara Therapeutics have currently?

Bicara Therapeutics has approximately 115 employees as of June 2026. Key team members to contact include Chief Executive Officer: C. M.Chief Commercial Officer: C. S.Chief Financial Officer: I. H.. For more team information and contact data, explore Bicara Therapeutics's employee directory with LeadIQ.

Bicara Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Bicara Therapeutics is a clinical-stage biotechnology company developing bifunctional antibodies designed to modulate tumors directly at the site of disease. Based in Boston, Massachusetts, and founded in 2020, the company is advancing its lead candidate, ficerafusp alfa (FICERA), a potentially first-in-class bifunctional antibody that pairs an EGFR-targeting component with a TGF-β ligand trap. The design aims to localize tumor targeting and deliver a modulating signal to counteract fibrosis, immunosuppression, and TGF-β–driven resistance within solid tumors.

The company operates in the biotechnology research industry and pursues improvements in immune cell penetration and durability of responses in cancer therapy. In January 2025, Bicara presented Phase 1/1b dose-expansion results with Ficerafusp Alfa in advanced squamous cancer of the anal canal at the ASCO Gastrointestinal Cancers Symposium.

Most Common Email Formats at Bicara Therapeutics

Frequently Asked Questions

What does Bicara Therapeutics do?

What is Bicara Therapeutics's email address format?

How many employees does Bicara Therapeutics have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Bicara Therapeutics Email Format

Verify Bicara Therapeutics email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Bicara Therapeutics

Frequently Asked Questions

What does Bicara Therapeutics do?

What is Bicara Therapeutics's email address format?

How many employees does Bicara Therapeutics have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Bicara Therapeutics Email Format

Verify Bicara Therapeutics email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.